Efficacy of DNA Methyltransferase Inhibitor Immune Priming Therapy in Combination with PD-1 Inhibitors to Treat High-Risk Pediatric Brain Tumors

Rachid Drissi(Nationwide Children's Hospital), Fiona Pakiam(Fred Hutch Cancer Center), Dhana Llivichuzhca-Loja(Yale University), Shiva Senthil Kumar(Nationwide Children's Hospital), Caterina Russo(McGill University Health Centre), Fupan Yao(Brain Tumour Research), Erin Crotty(Seattle Children's Hospital), Midori Clarke(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Shelli M. Morris(Center for Cancer and Blood Disorders), Emily J. Girard(Seattle Children's Hospital), Andrew Bondoc(Brain Tumour Research), Annie Huang(Hospital for Sick Children), Liza Konnikova(Yale University), James M. Olson(Fred Hutch Cancer Center), Margo Coxon(Fred Hutch Cancer Center), Banlanjo Abdulaziz Umaru(Nationwide Children's Hospital), James T. Rutka(Hospital for Sick Children), Maryam Fouladi(Nationwide Children's Hospital), Nada Jabado(McGill University), Dean Popovski(Uppsala University), Heather R. Conti(University of Dental Medicine), Xiaoting Zhu(Dazhou Central Hospital), Matthew C. Biery(Seattle Children's Hospital), Mi‐Youn Brusniak(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Augusto Faria Andrade(McGill University Health Centre), Mei Lü(Qilu Hospital of Shandong University), Michele Zeinieh(McGill University Health Centre), Ken Brasel(Center for Cancer and Blood Disorders)
bioRxiv (Cold Spring Harbor Laboratory)
May 18, 2025
Cited by 0


Related Papers